• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1999 Fiscal Year Final Research Report Summary

Genetic Analysis of vessel damege in Diabetics

Research Project

Project/Area Number 10672184
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Laboratory medicine
Research InstitutionKEIO UNIVERSITY

Principal Investigator

TAKEI Izumi  SHOOL OF MEDICINE KEIO UNIVERSITY, DEPARTMENT OF CLINICAL AND LABORATORY MEDICINE, ASSOCIATE PROFESSOR, 医学部・中央臨床検査部, 講師 (80129519)

Co-Investigator(Kenkyū-buntansha) KODAMA Keiichi  SHOOL OF MEDICINE KEIO UNIVERSITY, DEPARTMENT OF INTERNAL MEDICINE, POST GRADUATE, 医学部・内科, 助手 (70276236)
MIYAMOTO Kazunori  SHOOL OF MEDICINE KEIO UNIVERSITY, DEPARTMENT OF INTERNAL MEDICINE, POST GRADUATE, 医学部・内科, 助手 (70265784)
MURATA Mitsuru  SHOOL OF MEDICINE KEIO UNIVERSITY, DEPARTMENT OF INTERNAL MEDICINE, ASSOCIATE PROFESSOR, 医学部・内科, 講師 (50174305)
Project Period (FY) 1998 – 1999
KeywordsDIABETES / GENE / VESSEL DISTURBANCE
Research Abstract

(Purpuse) : Diabetes mellitus is related to vessel damage which are contained both microangiopathy and macroangiopathy. However, this mechanism has been unknoun, so, we examined genetic analysis of them for clarified mechanism.
(Method) : 290 diabetic patients were selected by the criteria of WHO 1985 about diabetes and were obtained informed consent. Retinopathy was diagnosed by ophthalmologist, diabetic nephropathy was decided due to the decision of national health department in Japan. Cardiovascular disease was decided by tredmill test and past history, and cerebral artery disease was dianosed by brain MRI examinations and past history. Genetic polymorphism was measured by direct polymerase chain amplification about clolesterol ester tranfer protein (CETP) Tag IB, parooxonase 192AKG/gln, platelet membrane GPIb/Iy 145T/1T, LDL : Pvu-II Hin III ser/step, plasminogen activator inhibitor (PAI-1), 5HT2A receptor, methylene tetrahydroforate reductase (MTHFR), e-NOS, ApoE, fibrinogen, mitodondrial 5178 and ACE Insertion/Deletion.
(Results and Conclusion) : Results of 12 genetic analysises, CETP was significantly related to macroangiopathy and serum LDL concentration. Paraoxonase Arg/Arg was significant high risk in diabetics with macroangiopathy. PAI-1 4G/4G was related to hypertension, but not correletion with micro and macroangiopathy. 5HT2A c/c, c/T was significant high risk at macroangiopathy by calcification degree using aorta CT scan (TES-100method). MTHFR T/T was related to macroangiopathy. On conclusion, several genetics were related to diabetic angiopathy.

  • Research Products

    (4 results)

All Other

All Publications (4 results)

  • [Publications] Meguro S, Takei I, Murata M: "Cholesteryl Ester Transfer Protein Polymorphism Is associated With Macroangiopathy In Japanese Type 2 Diabetes mellitus."Atherosclerosis. (in press). (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Takei I. Watanabe N: "Clinical Evaluation of Glycated Albumin Measurement."Diabetes Research and Clinical Practice. 50(1). 1349 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Suzuki T, Takei I: "Enhancement of insulin-related signal transductions by a protein-tyrosine phosphatase inhibitor Et-3,4-dephostatin in 3T3-L1 adipocytes."Diabetes. 49(1). 42 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ohashi N. Takei I, Murata M: "Relationships between the Promoter (4G/5G) Polymorphism of the PAI-1 Gene, PAI-1 Levels,Risk Factors and Complications in Japanese Type 2 Diabetes"Diabetes. 49(1). 93 (2000)

    • Description
      「研究成果報告書概要(和文)」より

URL: 

Published: 2002-03-26  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi